Fredun Pharmaceuticals Ltd share price logo

Fredun Pharma Share Price

1440.00

-39.05

(-2.64%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Fredun Pharma Stock Performance

as on January 9, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,430
    ₹1,499.7
    downward going graph

    0.69%

    Downside

    4.15%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹635
    ₹1,999
    downward going graph

    55.90%

    Downside

    38.82%

    Upside

    downward going graph

Fredun Pharma share price movements today

Previous Close
₹1,479.05
Open
₹1,499.70
Volume
13.39K
Upper Circuit
₹1,774.85
Lower Circuit
₹1,183.25
Day's Low - High
₹1,430 - ₹1,499.7
52 Week Low - High
₹635 - ₹1,999

Fredun Pharma Historical Returns

1 Month Return
-14.92 %
3 Month Return
+ 4.25 %
1 Year Return
+ 110.09 %
3 Year Return
+ 37.09 %
5 Year Return
+ 257.78 %

Fredun Pharma Fundamentals

as on January 9, 2026 at 4:01 pm IST

Market Cap

₹793.66 Cr

Return on Equity (ROE)

14.34

PE Ratio (TTM)

19.43

Return on capital employed (ROCE)

16.95

Industry PE ratio

42.86

Beta (LTM)

0.76

P/B Ratio

2.81

Dividend Yield

0

PEG Ratio

0.26

Quarterly Earnings Growth YOY

943

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Fredun Pharma Stock Valuation

as on January 9, 2026 at 4:01 pm IST

Fredun Pharma in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

March 28, 2025

Today (19.43x)

January 8, 2026

Industry (42.86x)

January 8, 2026

Highest (25.56x)

November 20, 2025

LowHigh

Today’s Price to Earnings Ratio: 19.43x

Fredun Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fredun Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA793.6651.56%0.0015348
NA777.34-8.36%0.0047661
NA4,385.58-6.39%1.88-34371
NA744.710.92%0.52250561
NA6,620.4330.67%0.592722,115

Fredun Pharma Share Price Target

Get share price movements and forecasts by analysts on Fredun Pharma .

Source: S&P Global Market Intelligence

Fredun Pharma Stock’s Investor Sentiment and Interest

Search interest for Fredun Pharmaceuticals Ltd Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-29% versus previous 30 day period

Fredun Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
-
-
286.27
165.44
119.4
143.59
Total Income
-
-
288.86
167.41
119.86
145.29
Expenses
-
-
251.2
150.16
102.86
122.96
Operating Profit
-
-
35.07
15.28
16.54
20.63
Operating Profit Margin %
0%
0%
12.25%
9.24%
13.85%
14.37%
Profit Before Interest, Tax and Depreciation
-
-
37.66
17.25
16.99
22.33
Interest
-
-
14.23
8.15
6.53
7.73
Depreciation
-
-
3.2
1.84
1.42
1.89
Profit Before Tax
-
-
20.23
7.26
9.04
12.71
Tax Paid
-
-
6.49
1.26
2.27
3.27
Profit After Tax
-
-
13.74
6
6.77
9.43
Total Net profit including share of profit / Loss from associate company
-
-
13.74
6
6.77
9.43
EPS
-
-
29.09
12.71
14.33
19.98
Actual EPS
-
-
29.09
12.71
14.33
19.98
Adjusted EPS
-
-
29.09
12.71
14.33
19.98
Diluted EPS
-
-
-
12.71
14.33
19.98

Fredun Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2025
Sales
451.71
Total Income
456.27
Expenses
401.36
Operating Profit
50.35
Operating Profit Margin %
11.15%
Profit Before Interest, Tax and Depreciation
54.91
Interest
22.38
Depreciation
5.04
Profit Before Tax
27.49
Tax Paid
7.75
Profit After Tax
19.74
Total Net profit including share of profit / Loss from associate company
19.74
EPS
44.83
Actual EPS
44.83
Adjusted EPS
44.83
Diluted EPS
44.83

Fredun Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
3.33
3.97
17.3
0.84
-10.64
0.17
-2.38
-14.41
-0.44
Cash Flow from Investing Activities
-7.39
-2.92
-1.28
-16.4
-1.49
-1.39
-4.15
-9.4
-7.64
Cash Flow from Financing Activities
3.45
2.53
-8.38
4.43
13.74
-0.71
7.48
25.18
6
Net Cash Flow
0.79
-0.64
0.7
0.01
1.59
-1.93
0.94
1.36
-2.08

Fredun Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
May 2023
Jun 2023
Aug 2023
Sep 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
50.15%
49.62%
49.62%
49.33%
49.31%
49.16%
49.17%
48.92%
49.17%
48.93%
48.93%
48.93%
48.93%
48.93%
DII
1.65%
1.64%
1.64%
1.61%
1.6%
1.6%
1.6%
1.59%
1.6%
1.59%
1.59%
1.59%
1.59%
1.6%
FII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.01%
Public
48.2%
48.74%
48.74%
49.06%
49.09%
49.25%
49.24%
49.49%
49.24%
49.48%
49.48%
49.48%
49.48%
49.45%
Total Outstanding Shares
45,32,272
45,80,122
45,80,122
46,44,290
46,84,162
46,99,162
46,99,162
47,21,662
46,99,162
47,21,662
47,21,662
47,21,662
47,21,662
47,21,662
Total Shareholders
4,521
4,609
4,625
4,632
6,313
6,837
7,507
6,840
7,511
8,018
8,121
7,976
7,906
8,120

Fredun Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Fredun Pharma .

  • Fredun Pharmaceuticals Ltd Earnings Results

    Fredun Pharmaceuticals Ltd’s net profit jumped 18.58% since last year same period to ₹6.00Cr in the Q4 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated -56.33% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Fredun Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 per share on 31 May 2025 - translating a dividend yield of 0.05%.

    Read More about Dividends

Insights on Fredun Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 0.01% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Fredun Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.9% return, outperforming this stock by 120.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 48.93% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Fredun Pharma stock has moved down by -14.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 49.48% to 49.45% in Sep 2025 quarter

About Fredun Pharmaceuticals Ltd

Established in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was eventually transformed into a public limited company in 1994. Initially, the promoters had set up D N Pharma to manufacture and export pharmaceutical pharmaceutical formulations to Afghanistan, West Africa and other nearby countries. However, starting from 1993, the company shifted to FPL which focused on developing tablet, capsules, dry syrups and ointments. It commenced commercial production in August 1994 with loan and license from Cipla and Merind.

Consequently, FPL was approved to be listed on the stock exchange in April 1996, and decided to use the funding for international expansion, repaying term loans, and reducing interest burden. Furthermore, FPL is continually registering its products across various countries with the hopes of increasing its overall turnover and boosting export orders. Currently, FPL is successfully registering drugs in countries such as Nepal, Tanzania, Uganda, and Sri Lanka.

Revenue: ₹143.59Cr as on September 2025 (Q2 FY26)
Net Profit: ₹9.43Cr as on September 2025 (Q2 FY26)
Chairperson Name: Daulat N Medhora
OrganisationFredun Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEODaulat N Medhora
E-voting on sharesClick here to vote

FAQs

What is Fredun Pharma share price today?

Fredun Pharma share price today stands at ₹1440 as on at the close of the market. Fredun Pharma share today touched a day high of ₹1499.7 and a low of ₹1430.

What is the 52 week high and 52 week low range for Fredun Pharma share?

Fredun Pharma touched a 52 week high of ₹1999 and a 52 week low of ₹635. Fredun Pharma share price today i.e. is closed at ₹1440, which is -27.96% down from its 52 week high and 126.77% up from its 52 week low.

What is Fredun Pharma 's market capitalisation today?

Fredun Pharma market capitalisation is ₹793.66 Cr as on .

How to buy Fredun Pharma shares?

To buy Fredun Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 539730 or Fredun Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Fredun Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Fredun Pharma trading volume today?

Fredun Pharma trading volume is 13.39K as on . This means that 13.39K shares of Fredun Pharma were bought and sold on the stock market during today's trading session.